Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,708 public trials 1,048 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

NCT03971474

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 889 locations
View Trial Details
Completed

Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)

NCT04385368

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Long Beach, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site West Hollywood, California, United States
View all 140 locations
View Trial Details
Completed

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

NCT03693612

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +33 more
Locations
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)

NCT03473925

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Honor Health ( Site 0005) Scottsdale, Arizona, United States
  • Florida Cancer Specialists ( Site 0003) Sarasota, Florida, United States
  • University of Maryland ( Site 0008) Baltimore, Maryland, United States
  • Henry Ford Health System ( Site 0006) Detroit, Michigan, United States
View all 14 locations
View Trial Details
Completed

Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782)

NCT03664024

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +13 more
Locations
  • University Of Colorado ( Site 0908) Aurora, Colorado, United States
  • Harry & Jeanette Weinberg Cancer Institute ( Site 0901) Baltimore, Maryland, United States
  • Henry Ford Health System ( Site 0903) Detroit, Michigan, United States
  • Kingston General Hospital ( Site 0800) Kingston, Ontario, Canada
View all 15 locations
View Trial Details

Related conditions